Ets1 encoding a transcription factor involved in b-cell differentiation is recurrently deleted and down-regulated in classical hodgkin's lymphoma

Haematologica

Volumn 97, Issue 10, 2012, Pages 1612-1614

  Overbeck, Birte Malaika ^a   Martin Subero, Jose Inaki ^b   Ammerpohl, Ole ^a   Klapper, Wolfram ^a   Siebert, Reiner ^a   Giefing, Maciej ^a,c  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY OF BARCELONA   (Spain)

^c INSTITUTE OF HUMAN GENETICS   (Poland)

Author keywords

Classical hodgkin's lymphoma; Deletion; ETS1; Loss of B cell identity; Transcription factor

Indexed keywords

TRANSCRIPTION FACTOR 7 LIKE 1; TRANSCRIPTION FACTOR E2A; TRANSCRIPTION FACTOR ETS 1; TRANSCRIPTION FACTOR PAX9;

B LYMPHOCYTE ACTIVATION; B LYMPHOCYTE DIFFERENTIATION; CLASSICAL HODGKIN LYMPHOMA; DNA METHYLATION; DOWN REGULATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; HUMAN; LETTER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE ACTIVATION;

B-LYMPHOCYTES; CELL DIFFERENTIATION; DNA METHYLATION; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; HODGKIN DISEASE; HUMANS; PROTO-ONCOGENE PROTEIN C-ETS-1; TRANSCRIPTION FACTORS;

EID: 84867241411     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2012.061770     Document Type: Letter

References (12)

1. Ushmorov A, Leithauser F, Sakk O, Weinhausel A, Popov SW, Moller P, et al. Epigenetic processes play a major role in B-cellspecific gene silencing in classical Hodgkin lymphoma. Blood. 2006;107(6):2493-500.
2. Ammerpohl O, Haake A, Pellissery S, Giefing M, Richter J, Balint B, et al. Array-based DNA methylation analysis in classical Hodgkin lymphoma reveals new insights into the mechanisms underlying silencing of B-cell specific genes. Leukemia. 2012;26(1):185-8.
3. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 2002;16(1):6-21.
4. Hertel CB, Zhou XG, Hamilton-Dutoit SJ, Junker S. Loss of B cell identity correlates with loss of B cell-specific transcription factors in Hodgkin/Reed-Sternberg cells of classical Hodgkin lymphoma. Oncogene. 2002;21(32):4908-20.
5. Mathas S, Janz M, Hummel F, Hummel M, Wollert-Wulf B, Lusatis S, et al. Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma. Nat Immunol. 2006;7(2):207-15.
6. Küppers R, Klein U, Schwering I, Distler V, Bräuninger A, Cattoretti G, et al. Identification of Hodgkin and Reed-Sternberg cell-specific genes by gene expression profiling. J Clin Invest. 2003;111(4):529-37.
7. Morin RD, Mendez-Lago M, Mungall AJ, Goya R, Mungall KL, Corbett RD, et al. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature. 2011;476(7360):298-303.
8. Pasqualucci L, Trifonov V, Fabbri G, Ma J, Rossi D, Chiarenza A, et al. Analysis of the coding genome of diffuse large B-cell lymphoma. Nat Genet. 2011;43(9):830-7.
9. Mullighan CG, Goorha S, Radtke I, Miller CB, Coustan-Smith E, Dalton JD, et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature. 2007;446(7137):758-64.
10. Singh AK, Swarnalatha M, Kumar V. c-ETS1 facilitates G1/S-phase transition by up-regulating cyclin E and CDK2 genes and cooperates with hepatitis B virus X protein for their deregulation. J Biol Chem. 2011;286(25):21961-70.
11. Barton K, Muthusamy N, Fischer C, Ting CN, Walunas TL, Lanier LL, et al. The Ets-1 transcription factor is required for the development of natural killer cells in mice. Immunity. 1998;9(4):555-63.
12. Eyquem S, Chemin K, Fasseu M, Chopin M, Sigaux F, Cumano A, et al. The development of early and mature B-cells is impaired in mice deficient for the Ets-1 transcription factor. Eur J Immunol. 2004;34(11):3187-96.